APA Alıntı

Pasipanodya, J. G., Smythe, W., Merle, C. S., Olliaro, P. L., Deshpande, D., Magombedze, G., . . . Gumbo, T. (2018). Artificial intelligence–derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis. Clin Infect Dis.

Chicago Stili Alıntı

Pasipanodya, Jotam G., Wynand Smythe, Corinne S. Merle, Piero L. Olliaro, Devyani Deshpande, Gesham Magombedze, Helen McIlleron, ve Tawanda Gumbo. "Artificial Intelligence–derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis." Clin Infect Dis 2018.

MLA Alıntı

Pasipanodya, Jotam G., et al. "Artificial Intelligence–derived 3-Way Concentration-dependent Antagonism of Gatifloxacin, Pyrazinamide, and Rifampicin During Treatment of Pulmonary Tuberculosis." Clin Infect Dis 2018.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..